Literature DB >> 216072

Psychiatric rehabilitation and long-term rehospitalization rates: the findings of two research studies.

J H Beard, T J Malamud, E Rossman.   

Abstract

Two controlled studies at Fountain House examined the influence of psychiatric rehabilitation services on rehospitalization. Study I, initiated in 1959, followed 252 experimental and 81 control subjects for 9 years. Study II, initiated in 1964, followed 40 experimental and 34 control subjects for 5 years. Experimental subjects had Fountain House services available, while controls did not. Additionally, experimental subgroups received systematic reaching-out services: home visits, telephone or letter contact. Study II findings essentially replicated study I. Followup was 96--97 percent complete. Three quarters of controls were rehospitalized within 5 years. Experimental subjects receiving reaching-out services for 2 years had significantly lower rehospitalization rates for the first 5 years in study I and the first 2 years in study II. Rehospitalizations were delayed, not prevented. Study I experimentals receiving 2 years of reaching-out services spent twice as long in the community before rehospitalization and 40 percent fewer days in the hospital than controls. Study II experimental subjects were in the community almost three times longer than controls before rehospitalization. Half of study I experimental subjects attended less than 10 times. Experimental subjects receiving reaching-out services attended twice as often as those not receiving reaching-out services. Low or nonattending experimentals had almost identical relapse rates (77 percent) as controls (74 percent), while, of experimentals having 100 or more visits, 37 percent were rehospitalized.

Entities:  

Mesh:

Year:  1978        PMID: 216072     DOI: 10.1093/schbul/4.4.622

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  17 in total

1.  Negative and supportive social interactions and quality of life among persons diagnosed with severe mental illness.

Authors:  P T Yanos; S Rosenfield; A V Horwitz
Journal:  Community Ment Health J       Date:  2001-10

2.  Effectiveness of technical assistance in the development of psychiatric rehabilitation programs.

Authors:  P B Nemec; R Forbess; M R Cohen; M D Farkas; E S Rogers; W Anthony
Journal:  J Ment Health Adm       Date:  1991

Review 3.  Supportive therapy for schizophrenia.

Authors:  Lucy A Buckley; Nicola Maayan; Karla Soares-Weiser; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-04-14

4.  Psychiatric hospitalization and community-based program attendance.

Authors:  J Junginger
Journal:  Psychiatr Q       Date:  1990

5.  Predictors of participation in community outpatient psychosocial rehabilitation in schizophrenia.

Authors:  Matthew M Kurtz; Jennifer Rose; Bruce E Wexler
Journal:  Community Ment Health J       Date:  2010-07-30

6.  Measuring participation in an evidence-based practice: illness management and recovery group attendance.

Authors:  Alan B McGuire; Kelsey A Bonfils; Marina Kukla; Laura Myers; Michelle P Salyers
Journal:  Psychiatry Res       Date:  2013-09-05       Impact factor: 3.222

7.  Residential facilities for the mentally ill: needs assessment and community planning.

Authors:  F L Randolph; R E Lindenberg; A Z Menn
Journal:  Community Ment Health J       Date:  1986

8.  Clinical and policy issues.

Authors:  J A Talbott
Journal:  Bull N Y Acad Med       Date:  1985-06

Review 9.  Telephone follow-up, initiated by a hospital-based health professional, for postdischarge problems in patients discharged from hospital to home.

Authors:  P Mistiaen; E Poot
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

10.  Outcome and risks of ultra-long-term treatment with an oral neuroleptic drug. Relationship between perazine serum levels and clinical variables in schizophrenic outpatients.

Authors:  A Pietzcker; A Poppenberg; J Schley; B Müller-Oerlinghausen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.